ABSTRACT
Today nowhere is it more apparent that conservative management is critical to the safety than in the treatment of men with testis cancer, in which the cure of allcomers is in excess of 97% at 10 years ( Fig. 4.1 ), though this is at a considerable price for a minority of patients. This chapter reviews this success; explains what is known about causation; discusses what men, by learning about this relatively rare disease, can do to try to reduce its occurrence and the delays in diagnosis that still occur because of the late detection of these tumors; and discusses what is being done today to reduce the late sequelae of treatment.
